{"version":"1.0","provider_name":"Insight Partners","provider_url":"https:\/\/www.insightpartners.com","author_name":"Cecilia Beard","author_url":"https:\/\/www.insightpartners.com\/ideas\/author\/cecilia-beard\/","title":"On track to diagnose 32,000 patients daily, Proscia is shaping the future of precision medicine","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"xtffhgMDkd\"><a href=\"https:\/\/www.insightpartners.com\/ideas\/proscia-leadership-story\/\">On track to diagnose 32,000 patients daily, Proscia is shaping the future of precision medicine<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.insightpartners.com\/ideas\/proscia-leadership-story\/embed\/#?secret=xtffhgMDkd\" width=\"600\" height=\"338\" title=\"&#8220;On track to diagnose 32,000 patients daily, Proscia is shaping the future of precision medicine&#8221; &#8212; Insight Partners\" data-secret=\"xtffhgMDkd\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.insightpartners.com\/wp-content\/uploads\/2026\/02\/JPM-2026-thumbnails-2.jpg","thumbnail_width":1280,"thumbnail_height":720,"description":"\u201cPathology hasn&#8217;t changed in 150 years,\u201d says David West, cofounder and CEO of Proscia, a digital pathology software company. West began his career studying biomedical engineering at Johns Hopkins, where he worked with scientists studying the use of computer vision and machine learning to predict cancer outcomes from prostate cancer images. \u201cWhen I started talking [&hellip;]"}